Piperine, a kind of natural
alkaloid found in peppers, has been reported to exhibit anti-oxidative and anti-
tumor activities, both in vitro and in vivo.
Interleukin-6 (IL-6) is an important
cytokine that activates the signal transduction, promotes
tumor cell
metastasis, and induces
malignancy, including in
gastric cancer. However, the effects of
piperine on
IL-6 expression in
gastric cancer cells have not yet been well defined. In this study, we investigated the effects of
piperine on the
IL-6 expression, and examined the underlying signaling pathways via RT-PCR, promoter studies and Western blotting in human
gastric cancer TMK-1 cells. Our results showed that
piperine inhibited interleukin-1β (IL-1β)-induced
IL-6 expression in a dose-dependent manner. In addition,
piperine also inhibited
IL-6 promoter activity. Experiments with
mitogen-activated protein kinase (MAPK) inhibitors and dominant negative mutant
p38 MAPK indicated that
p38 MAPK was essential for
IL-6 expression in the TMK-1 cells. Additionally,
signal transducer and activator of transcription 3 (STAT3) was also involved in the IL-1β-induced
IL-6 expression in
gastric cancer cells.
Piperine inhibited IL-1β-induced
p38 MAPK and STAT3 activation and, in turn, blocked the IL-1β-induced
IL-6 expression. Furthermore,
gastric cancer cells pretreated with IL-1β showed markedly enhanced invasiveness, which was partially abrogated by treatment with
IL-6 siRNA,
piperine, and inhibitors of
p38 MAPK and STAT3. These results suggest that
piperine may exert at least part of its anti-
cancer effect by controlling
IL-6 expression through the suppression of
p38 MAPK and STAT3.